These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22214327)

  • 1. Piperidine and pyrrolidine analogs as glycogen synthase activators; a patent evaluation (WO2011058122).
    Uto Y
    Expert Opin Ther Pat; 2012 Jan; 22(1):89-93. PubMed ID: 22214327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzisoxazole analogs as glycogen synthase activators, a patent evaluation (WO2011057956).
    Uto Y
    Expert Opin Ther Pat; 2012 Jun; 22(6):701-7. PubMed ID: 22519818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent pyrrolidine- and piperidine-based BACE-1 inhibitors.
    Iserloh U; Wu Y; Cumming JN; Pan J; Wang LY; Stamford AW; Kennedy ME; Kuvelkar R; Chen X; Parker EM; Strickland C; Voigt J
    Bioorg Med Chem Lett; 2008 Jan; 18(1):414-7. PubMed ID: 18023580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (WO2011057959) indole and indazole derivatives as glycogen synthase activators: a patent evaluation.
    Skaltsounis AL; Gaboriaud-Kolar N
    Expert Opin Ther Pat; 2011 Dec; 21(12):1925-9. PubMed ID: 21988345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel heterocyclic compounds as mGlu5 antagonists: WO2009015897.
    Doller D; Li G; Brodbeck RM; Thomsen C
    Expert Opin Ther Pat; 2010 Mar; 20(3):435-9. PubMed ID: 20180623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrrolidine and piperidine analogues of SC-57461A as potent, orally active inhibitors of leukotriene A(4) hydrolase.
    Penning TD; Chandrakumar NS; Desai BN; Djuric SW; Gasiecki AF; Liang CD; Miyashiro JM; Russell MA; Askonas LJ; Gierse JK; Harding EI; Highkin MK; Kachur JF; Kim SH; Villani-Price D; Pyla EY; Ghoreishi-Haack NS; Smith WG
    Bioorg Med Chem Lett; 2002 Dec; 12(23):3383-6. PubMed ID: 12419366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel 1,5-naphthyridine PI3Kδ inhibitors, an evaluation of WO2011075628.
    Norman P
    Expert Opin Ther Pat; 2011 Nov; 21(11):1805-10. PubMed ID: 21939430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of substituted 4-aminopiperidines and 3-aminopyrrolidines as potent MCH-R1 antagonists for the treatment of obesity.
    Kim N; Meyers KM; Mendez-Andino JL; Warshakoon NC; Ji W; Wos JA; Colson A; Mitchell MC; Davis JR; Pinney BB; Reizes O; Hu XE
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5445-50. PubMed ID: 16879961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-pot formation of piperidine- and pyrrolidine-substituted pyridinium salts via addition of 5-alkylaminopenta-2,4-dienals to N-acyliminium ions: application to the synthesis of (±)-nicotine and analogs.
    Peixoto S; Nguyen TM; Crich D; Delpech B; Marazano C
    Org Lett; 2010 Nov; 12(21):4760-3. PubMed ID: 20882970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR3 antagonists: a survey of the patent literature.
    Gong L; Wilhelm RS
    Expert Opin Ther Pat; 2009 Aug; 19(8):1109-32. PubMed ID: 19637977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New polyhydroxylated pyrrolidine, piperidine, and pyrrolizidine alkaloids from Scilla sibirica.
    Yamashita T; Yasuda K; Kizu H; Kameda Y; Watson AA; Nash RJ; Fleet GW; Asano N
    J Nat Prod; 2002 Dec; 65(12):1875-81. PubMed ID: 12502331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel class of succinyl-nitrile-based Cathepsin S inhibitors.
    Bekkali Y; Thomson DS; Betageri R; Emmanuel MJ; Hao MH; Hickey E; Liu W; Patel U; Ward YD; Young ER; Nelson R; Kukulka A; Brown ML; Crane K; White D; Freeman DM; Labadia ME; Wildeson J; Spero DM
    Bioorg Med Chem Lett; 2007 May; 17(9):2465-9. PubMed ID: 17379516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent synthetic strategy leading to structurally diverse pyrrolidines and piperidines from common gamma-aminoalkyl butenolide and aldehyde precursors.
    Aurrecoechea JM; Suero R; de Torres E
    J Org Chem; 2006 Nov; 71(23):8767-78. PubMed ID: 17081005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule antagonists of the CCR2b receptor. Part 2: Discovery process and initial structure-activity relationships of diamine derivatives.
    Moree WJ; Kataoka K; Ramirez-Weinhouse MM; Shiota T; Imai M; Sudo M; Tsutsumi T; Endo N; Muroga Y; Hada T; Tanaka H; Morita T; Greene J; Barnum D; Saunders J; Kato Y; Myers PL; Tarby CM
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5413-6. PubMed ID: 15454236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of 3-aryl piperidine analogs as potent and efficacious dopamine D4 receptor agonists.
    Wang X; Bhatia PA; Daanen JF; Latsaw SP; Rohde J; Kolasa T; Hakeem AA; Matulenko MA; Nakane M; Uchic ME; Miller LN; Chang R; Moreland RB; Brioni JD; Stewart AO
    Bioorg Med Chem; 2005 Aug; 13(15):4667-78. PubMed ID: 15896964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological studies on alicyclic amines. (II). Central actions of piperidine, pyrrolidine and piperazine.
    Kasé Y; Miyata T; Kamikawa Y; Kataoka M
    Jpn J Pharmacol; 1969 Jun; 19(2):300-14. PubMed ID: 5308835
    [No Abstract]   [Full Text] [Related]  

  • 17. Asperidines A-C, pyrrolidine and piperidine derivatives from the soil-derived fungus Aspergillus sclerotiorum PSU-RSPG178.
    Phainuphong P; Rukachaisirikul V; Saithong S; Phongpaichit S; Sakayaroj J; Srimaroeng C; Ontawong A; Duangjai A; Muangnil P; Muanprasat C
    Bioorg Med Chem; 2018 Aug; 26(15):4502-4508. PubMed ID: 30078607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imidazo[1,2-a]pyridines as cholesterol 24-hydroxylase (CYP46A1) inhibitors: a patent evaluation (WO2014061676).
    Uto Y
    Expert Opin Ther Pat; 2015 Mar; 25(3):373-7. PubMed ID: 25514969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regioselective synthesis and stereochemical structure of anti-tumor active dispiro[3H-indole-3,2'-pyrrolidine-3',3''-piperidine]-2(1H),4''-diones.
    Girgis AS
    Eur J Med Chem; 2009 Mar; 44(3):1257-64. PubMed ID: 18947903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
    Cheng XC; Wang Q; Fang H; Tang W; Xu WF
    Bioorg Med Chem; 2008 May; 16(10):5398-404. PubMed ID: 18440232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.